Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sympathetic Vasoconstriction and Insulin Resistance
NCT03318094Phase 1Active, not recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Oct 2017
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of phentolamine in insulin resistance (IR) and obesity (3 arms), sponsored by Vanderbilt University Medical Center. Primary endpoint: Contrast Enhanced-Ultrasonography. Started Oct 2017; status: active, not recruiting.
02
Drugs
phentolamine
03
Conditions
insulin resistance (IR)obesity
Beyond the preview
Go deeper on NCT03318094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03318094.